Anthem Biosciences Anticipated to Finalize IPO Allotment Today; Verify Allocation Status Online as GMP Surges 25%
In a significant development for the Indian stock market, the much-anticipated Initial Public Offering (IPO) of Anthem Biosciences has concluded, and investors can now check their allotment status online. The Anthem Biosciences IPO, which was part of the BSE Sensex and NSE, was structured as a 100% book-built issue and was an Offer for Sale (OFS), with promoters and existing shareholders offloading approximately 5.96 crore equity shares.
The shares are expected to list on the BSE and NSE on July 21, 2025. The Anthem Biosciences IPO was priced at Rs 570 per share, and no fresh equity was issued in this round. Kfin Technologies has been appointed as the registrar for the Anthem Biosciences IPO, overseeing the allotment and refund process.
Investors who participated in the Anthem Biosciences IPO can now check their allotment status online. Here's a step-by-step guide on how to do so:
**Via KFin Technologies:** - Visit the KFin Technologies IPO status page. - Select “Anthem Biosciences IPO” from the dropdown menu. - Choose your identification method: PAN, Application Number, DP/Client ID, or Bank Account Number. - Enter the required details and click on Search to view your allotment status.
**Via NSE:** - Go to the NSE IPO Bid Details page. - Click on Equity and SME IPO Bid Details. - Select Anthem Biosciences IPO from the dropdown. - Enter your PAN and Application Number. - Click Submit to view your allotment details.
**Via BSE:** - Visit the BSE website and navigate to the IPO allotment status page. - Enter your application number and PAN to check your allotment status.
It's worth noting that Anthem Biosciences, established in 2006, is a Bengaluru-based Contract Research, Development, and Manufacturing Organization (CRDMO). The company specializes in the production of fermentation-based active pharmaceutical ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. Its client base spans 44 countries, including both emerging startups and multinational pharma giants.
JM Financial, a diversified and integrated financial services group, is leading the IPO of Anthem Biosciences as the book-running manager. The firm's Mortgage Lending business includes wholesale lending focused on real estate developers and retail lending offering affordable home loans and secured loans to MSMEs. The Integrated Investment Banking (IB) segment serves institutional, corporate, government, and ultra-high-net-worth clients, offering services such as investment banking, institutional equities and research, private equity funds, fixed income, private wealth management, portfolio management services (PMS), syndication, and finance.
In addition, JM Financial's Alternative and Distressed Credit segment covers the asset reconstruction business and alternative credit funds. The firm's Asset Management, Wealth Management, and Securities (Platform AWS) segment offers a comprehensive investment platform for individual clients, including elite and retail wealth management, broking, and mutual fund services.
With the Anthem Biosciences IPO allotment status now available, investors can look forward to the listing of the shares on July 21, 2025. For more information, investors are advised to visit the official websites of KFin Technologies, the BSE, and the NSE.
[1] - Source:
- The Anthem Biosciences IPO, a significant event for the Indian stock market, has concluded, allowing investors to check their allotment status online.
- The shares of Anthem Biosciences, a Bengaluru-based CRDMO, are expected to list on the BSE and NSE on July 21, 2025.
- For those who participated in the Anthem Biosciences IPO, the allotment status can be checked via KFin Technologies, NSE, or BSE websites following specific steps provided.
- JM Financial, a diversified financial services group, is leading the IPO of Anthem Biosciences and offers services ranging from investment banking to mortgage lending, private equity funds, and asset management.
